Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the Dementia Study in Northern Norway

BMC Geriatrics

Volumn 11, Issue , 2011, Pages

  Andersen, Fred ^a,b   Viitanen, Matti ^c,d   Halvorsen, Dag S ^e   Straume, Bjørn ^a   Engstad, Torgeir A ^e  

^a UNIVERSITY OF TROMSØ   (Norway)

^b Árran Lule Sami centre   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; FEMALE; HEALTH SURVEY; HUMAN; MALE; METHODOLOGY; NORWAY; POLYPHARMACY; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; NORWAY; POLYPHARMACY; POPULATION SURVEILLANCE; PRESCRIPTION DRUGS;

EID: 80053550375     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-11-58     Document Type: Article

References (48)

1. Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Aarsland D, Rongve A, Nore SP, Skogseth S, Skulstad S, Ehrt U, Hoprekstad D, Ballard C, Dement Geriatr Cogn Disord 2008 26 445 452 10.1159/000165917 18974647
2. Incidence and subtypes of dementia in three elderly populations of central Spain. Bermejo-Pareja F, ito-Leon J, Vega S, Medrano MJ, Roman GC, J Neurol Sci 2008 264 63 72 10.1016/j.jns.2007.07.021 17727890 (Pubitemid 350193244)
3. Prevalence of stress, anxiety and depression in with Alzheimer caregivers. Ferrara M, Langiano E, Di BT, De VE, Di CL, Bauco C, Health Qual Life Outcomes 2008 6 93 10.1186/1477-7525-6-93 18990207
4. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention. Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H, CNS Drugs 2002 16 435 444 10.2165/00023210-200216070-00001 12056919 (Pubitemid 34729148)
5. Prevalence of dementia in the United States: the aging, demographics, and memory study. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB, Neuroepidemiology 2007 29 125 132 10.1159/000109998 17975326 (Pubitemid 350191430)
6. Design of comprehensive Alzheimer's disease centers to address unmet national needs. Trojanowski JQ, Arnold SE, Karlawish JH, Burden K, Cary M, Davatzikos C, Detre J, Gaulton G, Grossman M, Hurtig H, Jedrziewski K, McCluskey L, Naylor M, Polsky D, Schellenberg GD, Siderowf A, Shaw LM, Van DV, Wang LS, Werner R, Xie SX, Lee VM, Alzheimers Dement 2010 6 150 155 10.1016/j.jalz.2009. 11.004 20298979
7. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Brookmeyer R, Gray S, Kawas C, Am J Public Health 1998 88 1337 1342 10.2105/AJPH.88.9.1337 9736873 (Pubitemid 28402270)
8. The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project. Wimo A, Jonsson L, Gustavsson A, McDaid D, Ersek K, Georges J, Gulacsi L, Karpati K, Kenigsberg P, Valtonen H, Int J Geriatr Psychiatry 2010 28
9. Comorbidity profile of dementia patients in primary care: are they sicker? Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, Unverzaget F, Hendrie HC, J Am Geriatr Soc 2006 54 104 109 10.1111/j.1532-5415. 2005.00543.x 16420205
10. Current treatments for sleep disturbances in individuals with dementia. Deschenes CL, McCurry SM, Curr Psychiatry Rep 2009 11 20 26 10.1007/s11920-009- 0004-2 19187704
11. Anticholinergic drug use and risk for dementia: target for dementia prevention. Jessen F, Kaduszkiewicz H, Daerr M, Bickel H, Pentzek M, Riedel-Heller S, Wagner M, van den Bussche H, Broich K, Maier W, Eur Arch Psychiatry Clin Neurosci 2010 260 111 115 10.1007/s00406-010-0156-4
12. Daily medication use in nursing home residents with advanced dementia. Tjia J, Rothman MR, Kiely DK, Shaffer ML, Holmes HM, Sachs GA, Mitchell SL, J Am Geriatr Soc 2010 58 880 888 10.1111/j.1532-5415.2010.02819.x 20406320
13. Beyond the beers criteria: A comparative overview of explicit criteria. Levy HB, Marcus EL, Christen C, Ann Pharmacother 2010 44 1968 1975 10.1345/aph.1P426 21081709
14. Treating nondementia illnesses in patients with dementia. Brauner DJ, Muir JC, Sachs GA, JAMA 2000 283 3230 3235 10.1001/jama.283.24.3230 10866871 (Pubitemid 30422041)
15. Developing explicit positive beers criteria for preferred central nervous system medications in older adults. Stefanacci RG, Cavallaro E, Beers MH, Fick DM, Consult Pharm 2009 24 601 610 10.4140/TCP.n.2009.601 19689175
16. Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mail. Andersen F, Engstad T, Straume B, Viitanen M, Halvorsen DS, Hykkerud S, Sjobrend K, BMC Med Res Methodol 2010 10 35 10.1186/1471-2288-10-35 20429946
17. Welcome to ICD-10. Bebbington P, Soc Psychiatry Psychiatr Epidemiol 1992 6 255 257
18. Diagnosing dementia - ICD-10 not so bad after all: a comparison between dementia criteria according to DSM-IV and ICD-10. Naik M, Nygaard HA, Int J Geriatr Psychiatry 2008 3 279 282 (Pubitemid 351404022)
19. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P, Lancet Neurol 2007 6 734 746 10.1016/S1474-4422(07)70178-3 17616482 (Pubitemid 47058377)
20. Validation of the DINAMAP ProCare blood pressure device according to the international protocol in an adult population. Reinders A, Reggiori F, Shennan AH, Blood Press Monit 2006 11 293 296 10.1097/01.mbp.0000217998.96967.fb 16932038 (Pubitemid 44319048)
21. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Folstein MF, Folstein SE, McHugh PR, J Psychiatr Res 1975 12 189 198 10.1016/0022-3956(75)90026-6 1202204
22. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, Grafman JH, J Am Geriatr Soc 1989 37 725 729 2754157 (Pubitemid 19199790)
23. Comparison of two cognitive rating scales in medically ill patients. Burch EA, Andrews SR, Int J Psychiatry Med 1987 2 193 200
24. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J, Neurology 1994 12 2308 2314 (Pubitemid 24382728)
25. Cardiovascular risk and memory in non- demented elderly women. Wang S, Jacobs D, Andrews H, Tsai WY, Luo X, Bergmann C, Sano M, Neurobiol Aging 2010 31 1250 1253 10.1016/j.neurobiolaging.2008.08.007 18805604
26. Health co-morbidities in ageing persons with Down syndrome and Alzheimer's dementia. McCarron M, Gill M, McCallion P, Begley C, J Intellect Disabil Res 2005 49 560 566 10.1111/j.1365-2788.2005.00704.x 15966964 (Pubitemid 40932410)
27. [Anatomic-therapeutic-chemical classification of drugs]. Skrbo A, Zulic I, Hadzic S, Gaon ID, Med Arh 1999 53 57 60 10870628
28. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. Carnahan RM, Lund BC, Perry PJ, Polloc BG, Culp KR, J Clin Pharmacol 2006 46 1481 1486 10.1177/0091270006292126 17101747 (Pubitemid 44704208)
29. Drugs used in dementia in the elderly. National Prescribing Service Limited A. NPS News 59, 2008
30. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE, Arch Intern Med 2008 168 508 513 10.1001/archinternmed.2007.106 18332297 (Pubitemid 351547214)
31. Low blood pressure and dementia in elderly people: the Kungsholmen project. Guo Z, Viitanen M, Fratiglioni L, Winblad B, BMJ 1996 312 805 808 8608286 (Pubitemid 26099298)
32. Demented versus non-demented very old inpatients: the same comorbidities but poorer functional and nutritional status. Zekry D, Herrmann FR, Grandjean R, Meynet MP, Michel JP, Krause KH, Age Ageing 2008 37 83 89 17971391 (Pubitemid 351146981)
33. Burden of Alzheimer's disease and association with negative health outcomes. Malone DC, McLaughlin TP, Wahl PM, Leibman C, Arrighi HM, Cziraky MJ, Mucha LM, Am J Manag Care 2009 15 481 488 19670951
34. Change in blood pressure and incident dementia: a 32-year prospective study. Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ, Hypertension 2009 54 233 240 10.1161/HYPERTENSIONAHA.109.128744 19564551
35. Potential predictors of hippocampal atrophy in Alzheimer's disease. Dhikav V, Anand K, Drugs Aging 2011 28 1 11 10.2165/11586390-000000000-00000 21174483
36. APOE, vascular pathology, and the AD brain. Yip AG, McKee AC, Green RC, Wells J, Young H, Cupples LA, Farrer LA, Neurology 2005 65 259 265 10.1212/01.wnl.0000168863.49053.4d 16043796 (Pubitemid 41022371)
37. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. van Beek AH, Claassen JA, Rikkert MG, Jansen RW, J Cereb Blood Flow Metab 2008 28 1071 1085 10.1038/jcbfm.2008.13 18349877 (Pubitemid 351733344)
38. Risk factors for vascular dementia: hypotension as a key point. Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G, Vasc Health Risk Manag 2008 4 395 402 18561514 (Pubitemid 351711967)
39. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Qiu C, von SE, Fastbom J, Winblad B, Fratiglioni L, Arch Neurol 2003 60 223 228 10.1001/archneur.60.2.223 12580707 (Pubitemid 36193966)
40. Prevalence of comorbidity of chronic diseases in Australia. Caughey GE, Vitry AI, Gilbert AL, Roughead EE, BMC Public Health 2008 8 221 10.1186/1471-2458-8-221 18582390 (Pubitemid 352019972)
41. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox HD, Dale W, J Am Geriatr Soc 2008 56 1306 1311 10.1111/j.1532-5415.2008.01741.x 18482301
42. Prevalence and outcomes of use of potentially inappropriate medicines in older people: cohort study stratified by residence in nursing home or in the community. Barnett K, McCowan C, Evans JM, Gillespie ND, Davey PG, Fahey T, Qual Saf Health Care 2011 20 275 281 10.1136/bmjqs.2009.039818
43. Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: A prospective study. Uusvaara J, Pitkala KH, Kautiainen H, Tilvis RS, Strandberg TE, Drugs Aging 2011 28 131 138 10.2165/11585060-000000000-00000 21275438
44. The appropriateness of drug use in an older nondemented and demented population. Giron MS, Wang HX, Bernsten C, Thorslund M, Winblad B, Fastbom J, J Am Geriatr Soc 2001 49 277 283 10.1046/j.1532-5415.2001.4930277.x 11300238 (Pubitemid 32240294)
45. The development of new therapeutics for Alzheimer's disease. Carter MD, Simms GA, Weaver DF, Clin Pharmacol Ther 2010 88 475 486 10.1038/clpt.2010.165 20811351
46. Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease. Konishi K, Hori K, Uchida H, Watanabe K, Tominaga I, Kimura M, Shibasaki T, Kataoka A, Hachisu M, Psychogeriatrics 2010 10 34 38 10.1111/j.1479-8301.2010.00310.x 20594285
47. The cognitive impact of anticholinergics: a clinical review. Campbell N, Boustani M, Limbil T, Ott C, Fox C, Maidment I, Schubert CC, Munger S, Fick D, Miller D, Gulati R, Clin Interv Aging 2009 4 225 233 19554093
48. Drug Burden Index and Beers Criteria: Impact on Functional Outcomes in Older People Living in Self-Care Retirement Villages. Gnjidic D, Le Couteur DG, Abernethy DR, Hilmer SN, J Clin Pharmacol 2011